维普期刊资源整合服务平台（V6.5）

维普中文期刊产品整合服务

18篇 您的检索式：作者名="ZUBIN A"

选中清除导出查看参考文献查看引证文献引用追踪共1页首页上一页第1页下一页末页 /1 跳转

		题名	作者	年代	出处	被引量
	1	Education of pharmacists in Canada 显示文摘	ZUBIN A MARY H H	2008	Am J Pharm Educat2008，72，6：	1
	2	Development and validation oro- cesses for an objective structured clinical examination(OSCE) for entry-to-practice certification in pharmacy: the Canadian experience 显示文摘	Zubin A Carol OB John P	2003	A m J Pharm Educ2003，67，3：	1
	3	Development and validation or ocesses for an objective structured clinical examination(OSCE)for entry-to-practice certification in pharmacy:the Canadian experience显示文摘	Zubin A Carol OB John P		0，，03：	1
	4	Instructional design and assessment development and validation processes for an ob- jective clinical examination(OSCE)for entry-to-practice cer- tification in pharmacy: The Canadian experienee显示文摘	Zubin A Carol OB JohnP	2003	Am J Phar2003，67，3：	1
	5	Instructional design and assess ment development and validation processes for an objective clinical examination (OSCE) for entry - to - practice certification in pharmacy : The Canadianexperi- ence 显示文摘	ZUBIN A CAROL 0 B JOHNP	2003	Am J Pharm Educ2003，67，3：	1
	6	Instructional design and assessment development and validation processes for an ob- jective structured clinical examination (OSCE) for entry-to- practice certification in pharmacy:The Canadian experience 显示文摘	Zubin A Carol OB Johny P	2003	Am J Pharm Educ2003，67，3：	1
	7	Instructional design and assessment development and validation processes for an objective clinical examination(OSCE)for entry to practice certification in pharmacy:The Canadian experience显示文摘	Zubin A Carol OB John P	2003	Am J Pharm Educ2003，67，3：	1
	8	Instructional design and assessment development and validationprocesses for an objective clinical examination(OSCE)for entry to Practice certification in pharmacy:The Canadian experience显示文摘	Zubin A Carol OB John P	2003	Am J Pharm Educ2003，67，3：	1
	9	Oligonucleotides with 2′-O-carboxymethyl group:synthesis and 2′-conjugation via amide bond formation on solid phase显示文摘	Kachalova A Zubin E Stetsenko D	2004	Org Biomo Chem2004，2，19：	1
	10	Instructional design and assessment development and validation processes for an objective clinical examination (OSCE) for entry to practice certification in pharmacy: The Canadian experience 显示文摘	Zubin A Carol OB John P	2003	Am J Pharm Educ2003，67，3：	1
	11	Instructional design and assessment development and validation processes for an objective clinical examination(OSCE)for entry to practice certification in pharmacy:the canadian experience显示文摘	Zubin A Carol OB John P	2003	Am J Pharm Educ2003，67，3：	1
	12	Instructional design and assessment development and validation processes for an objective clinical examination(OSCE) for entry-to-practice certification in pharmacy:The Canadian experience显示文摘	ZUBIN A CAROL O B JOHN P	2003	Am J Pharm Educ2003，67，3：	1
	13	Development and validation o for an objective structured clinical exemination(OSCE) for entry-to-prac- tice ceification in phamtay: the Canadian expexience显示文摘	Zubin A Carol O B John P	2003	Am J Pharm FMuc2003，67，3：	1
	14	Instructional design and assess- ment development and validation processes for an objective clinical examination(OSCE) for entry to Practice certification in pharma- cy: The Canadian experience 显示文摘	Zubin A Carol OB John P	2003	Am J Pharm Educ2003，67，3：	1
	15	Cladding ofNiCrBSi coatings with a high power diode laser显示文摘	Conde A Zubin F de Damborenea Y J	2002	Materials Science and Engineering A2002，334，12：	1
	16	Instructional design and assessment development and validation processes for an objective clinical examination ( OSCE ) for entry - to - practice certification in pharmacy: The Canadian experience 显示文摘	ZUBIN A CAROL O B JOHNP	2003	Am J Pharm Edue2003，67，3：	1
	17	Instructional design and assessment development and validation processes f or an objective clinical examination ( OSCE ) for entry to Practice certification in pharmacy: The Canadian experience显示文摘	Zubin A Carol OB John P	2003	Am J Pharm Educ2003，67，3：	1
	18	Ohio solid organ transplantation consortium criteria for liver transplantation in patients with alcoholic liver disease显示文摘AIM To evaluate risk of recidivism on a case-by-case basis.METHODS From our center's liver transplant program,we selected patients with alcoholic liver disease who were listed for transplant based on Ohio Solid Organ Transplantation Consortium(OSOTC) exception criteria.They were considered to have either a low or medium risk of recidivism,and had at least one or three or more months of abstinence,respectively.They were matched based on gender,age,and Model for End-Stage Liver Disease(MELD) score to controls with alcohol-induced cirrhosis from Organ Procurement and Transplant Network data.RESULTS Thirty six patients with alcoholic liver disease were approved for listing based on OSOTC exception criteria and were matched to 72 controls.Nineteen patients(53%) with a median [Inter-quartile range(IQR)] MELD score of 24(13) received transplant and were followed for a median of 3.4 years.They were matched to 38 controls with a median(IQR) MELD score of 25(9).At one and five years,cumulative survival rates(± standard error) were 90% ± 7% and 92% ± 5% and 73% ± 12% and 77% ± 8% in patients and controls,respectively(Log-rank test,P = 0.837).Four(21%) patients resumed drinking by last follow-up visit.CONCLUSION Compared to traditional criteria for assessment of risk of recidivism,a careful selection process with more flexibility to evaluate eligibility on a case-by-case basis can lead to similar survival rates after transplantation.	Kaveh Hajifathalian Annette Humberson Mohamad A Hanouneh David S Barnes Zubin Arora Nizar N Zein Bijan Eghtesad Dympna Kelly Ibrahim A Hanouneh	2016	World Journal of Hepatology2016，8，27：	0

返回顶部每页显示：

共1页首页上一页第1页下一页末页 /1 跳转

goolge学术搜索-维普

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1　渝公网安备 50019002500403号　违法和不良信息举报中心

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费